Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wittman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Medicinal Chemistry|December 14, 2001
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476T J Altstadt, C R Fairchild, J Golik, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
ACS Medicinal Chemistry Letters|March 18, 2021
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1Andrew P Degnan, Godwin K Kumi, Christopher W Allard, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Journal of Medicinal Chemistry|September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical developmentMark D Wittman, Joan M Carboni, Zheng Yang, et al.
Physical Review Letters|July 23, 2016
Demonstration of Fuel Hot-Spot Pressure in Excess of 50 Gbar for Direct-Drive, Layered Deuterium-Tritium Implosions on OMEGAS P Regan, V N Goncharov, I V Igumenshchev, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Medicinal Chemistry|December 14, 2001
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476T J Altstadt, C R Fairchild, J Golik, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
ACS Medicinal Chemistry Letters|March 18, 2021
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1Andrew P Degnan, Godwin K Kumi, Christopher W Allard, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Journal of Medicinal Chemistry|September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical developmentMark D Wittman, Joan M Carboni, Zheng Yang, et al.
Physical Review Letters|July 23, 2016
Demonstration of Fuel Hot-Spot Pressure in Excess of 50 Gbar for Direct-Drive, Layered Deuterium-Tritium Implosions on OMEGAS P Regan, V N Goncharov, I V Igumenshchev, et al.
Pageof 3